274 related articles for article (PubMed ID: 30555547)
1. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
[TBL] [Abstract][Full Text] [Related]
2. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
[TBL] [Abstract][Full Text] [Related]
4. MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma.
Zhou W; Liu Y; Gao Y; Cheng Y; Chang R; Li X; Zhou Y; Wang S; Liang L; Duan C; Zhang C
Cancer Lett; 2020 Jul; 483():75-86. PubMed ID: 32360180
[TBL] [Abstract][Full Text] [Related]
5. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
Li H; Jiang X; Niu X
Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
[TBL] [Abstract][Full Text] [Related]
7. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
9. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of
Zhang J; Wang Y; Shen Y; He P; Ding J; Chen Y
Theranostics; 2018; 8(10):2884-2895. PubMed ID: 29774081
[No Abstract] [Full Text] [Related]
10. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
11. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
12. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
13. MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.
Mariotti S; Barravecchia I; Vindigni C; Pucci A; Balsamo M; Libro R; Senchenko V; Dmitriev A; Jacchetti E; Cecchini M; Roviello F; Lai M; Broccoli V; Andreazzoli M; Mazzanti CM; Angeloni D
Oncotarget; 2016 Jan; 7(2):1808-25. PubMed ID: 26689989
[TBL] [Abstract][Full Text] [Related]
14. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
17. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer.
Han Y; Tan Y; Zhao Y; Zhang Y; He X; Yu L; Jiang H; Lu H; Tian H
J Cell Mol Med; 2020 May; 24(10):5491-5500. PubMed ID: 32227572
[TBL] [Abstract][Full Text] [Related]
18. NIR promotes progression of colorectal cancer through regulating RB.
Li Y; Wang L; Liu X; Zhang C; Du X; Xing B
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118856. PubMed ID: 32931817
[TBL] [Abstract][Full Text] [Related]
19. The novel circSLC6A6/miR-1265/C2CD4A axis promotes colorectal cancer growth by suppressing p53 signaling pathway.
Rong Z; Luo Z; Fu Z; Zhang P; Li T; Zhang J; Zhu Z; Yu Z; Li Q; Qiu Z; Huang C
J Exp Clin Cancer Res; 2021 Oct; 40(1):324. PubMed ID: 34656159
[TBL] [Abstract][Full Text] [Related]
20. MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation.
Wang Y; Deng W; Zhang Y; Sun S; Zhao S; Chen Y; Zhao X; Liu L; Du J
Acta Physiol (Oxf); 2018 Feb; 222(2):. PubMed ID: 28719045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
